Marker Therapeutics is trading at $1.23, up +6.03%, with biotech-sector strength the clearest available support for the move; a direct link is unconfirmed.
- The biotech sector is up 2.10% in the supplied market context.
- No new company-specific announcement explaining the October 21 move surfaced in the search.
- Marker Therapeutics announced a $2.6 million FDA grant on October 19, but that earlier news does not establish the cause of today’s gain.